Page 4 - Constituent Update News Today

The Council for Responsible Nutrition and the Natural Products Association have slammed the Food and Drug Administration (FDA) for delaying a decision on the regulatory status of NAC (N-acetyl-L-cysteine) in dietary supplements, as the Agency issues ‘tentative responses’ to two Citizen’s Petitions.

In a November 19, 2021 Constituent Update, FSIS announced that it has posted its after-action review report for the investigation of a 2018 multi-state outbreak of Lm illnesses associated with ready-to-eat, Asian-style pork patty products that resulted in 4 hospitalizations

To embed, copy and paste the code into your website or blog: The U.S. Food and Drug Administration (FDA) has recently signaled its continued interest in developing a voluntary “healthy” symbol for packaged foods as a representation of the nutrient content claim. Quantitative research on voluntary “healthy” symbol On 7 May 2021, the FDA issued a notice in the Federal Register announcing that it is conducting preliminary quantitative consumer research on symbols that could be used in the ...

FDA is not worried about the safety of specific lots of canola seed and “a small number of canola fields” for human and animal consumption that inadvertently were contaminated with low levels of two new genetically modified varieties of canola seed currently undergoing premarket food safety reviews. But, the agency’s lack of concern about the contamination should not be mistaken for an endorsement of the varietals’ safety in broader use, yet, FDA notes in an ...

To embed, copy and paste the code into your website or blog: The U.S. Food and Drug Administration (FDA) recently issued updated guidance that extends agency enforcement discretion over compliance with the requirement that domestic and foreign food facilities provide a unique facility identifier (UFI) when registering or renewing an existing food facility registration. Food facilities now have until 31 December 2022 to obtain and submit a UFI with their registration. FDA UFI food facility regis...

Monday, February 22, 2021 FDA will evaluate claims and other information on a dietary supplement’s website to establish the product’s “intended use.”  In general, a dietary supplement is allowed to make claims about having an effect on the “structure” or a “function” of the human body.  If FDA finds that the product is intended for use in the cure, mitigation, treatment, or prevention of disease, it will be deemed a “drug” under section 201(g)(1)(B) of the Federa...

On December 16, 2020, the U.S. Food and Drug Administration (“FDA”) issued a corporate Warning Letter to Whole Foods Market (“Whole Foods”) following 32 recalls Whole Foods conducted...

Following a series of Warning Letters issued throughout 2020 related to recalls due to allergen labelling errors, the U.S. Food and Drug Administration (FDA) recently issued a...